LEVOLTA is developing custom formulations of pharmaceutical products that currently generate unwanted side effects. oledronic acid, one of the most frequently prescribed intravenous drugs for treating rheumatoid arthritis, often creates severe flu symptoms and other complications. Through a proprietary reformulation of an existing product, Levolta has achieved comparable therapeutic results for patients while greatly reducing side effects. Several other drugs are also in reformulation.